Twist Bioscience Corporation

TWST

Healthcare

$59.38+4.73%vs prev close

$23.30

$66.06

52W RangeNear 52W High

+9.41 (+18.77%)Past 1M

Price

Stock Timeline

Institutional Holders

1 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

5,033,082

Portfolio Weight

2.19%

in ETF 8.46%

Est. Value

$283M

30D Net

-$20M

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Strong Buy

Buy

Hold

Analyst Targets

avg.

$61.88

vs Current ▲ +3.6% upside

Current$59.75

Low ~ High$36.00 ~ $70.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Leerink Partners

Outperform

$70.00

+17.15%

$56.70

Upgrade

2026-05-05

Barclays

Overweight

$65.00

+8.79%

$56.70

Maintain

2026-05-05

Guggenheim

Buy

$60.00

+0.42%

$56.70

Maintain

2026-05-05

Baird

Outperform

$65.00

+8.79%

$56.70

Maintain

2026-05-05

Barclays

Overweight

$55.00

-7.95%

$57.41

Maintain

2026-04-14

1 / 1

Avg Target

$61.88

vs Current ▲ +3.6% upside

Strong Buy

10 analysts

Strong Buy 1Buy 8Hold 1

Low $36.00

Current $59.75

High $70.00

Firm	Position	Target	Upside	Close	Action	Date
Leerink Partners	Outperform	$70.00	+17.15%	$56.70	Upgrade	26.05.05
Barclays	Overweight	$65.00	+8.79%	$56.70	Maintain	26.05.05
Guggenheim	Buy	$60.00	+0.42%	$56.70	Maintain	26.05.05
Baird	Outperform	$65.00	+8.79%	$56.70	Maintain	26.05.05
Barclays	Overweight	$55.00	-7.95%	$57.41	Maintain	26.04.14

1 / 1

Price Information

Previous Close$56.19

Open$58.32

Day Range$55.67 - $60.44

52-Week Range$23.30 - $66.06

1-Year Change71.42%

Trading Volume

Volume1,565,867

Avg Volume (3mo)1,271,522

Valuation

Market Cap3.5B

Book Value$7.44

Shares Outstanding62,271,314

Financials

Revenue (TTM)409.5M

Net Income-81,276,000

EPS$-1.32

EBITDA-109,835,000

Profitability

P/E Ratio-

P/B Ratio7.62

Return on Equity (ROE)-18.16%

Return on Assets (ROA)-12.93%

Profit Margin-19.85%

EV/EBITDA-31.59

Beta2.23

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)48.33

Company Overview

Twist Bioscience Corporation is a leading manufacturer of synthetic DNA, offering a wide range of DNA-based products and services. Their offerings include synthetic genes, oligo pools, and NGS tools used across various industries like therapeutics, diagnostics, and research. The company is positioned as a key enabler of innovation in biotechnology and life sciences through its DNA synthesis platform.

P/B

7.62

High valuation

ROE

-18.2%

Net loss

Beta

2.23

Extreme volatility

RSI(14)

48.3

Neutral

AI-generated summary. Not investment advice.